# OnCo record targeted-therapy-term (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/targeted-therapy-term/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "targeted-therapy-term" ;
  schema:name "Targeted therapy"@en ;
  schema:alternateName "targeted therapies"@en, "targeted drug"@en, "targeted drugs"@en, "targeted treatment"@en, "targeted treatments"@en, "targeted agent"@en, "targeted agents"@en, "molecularly targeted"@en, "precision oncology"@en, "precision medicine"@en, "personalised medicine"@en, "personalized medicine"@en, "actionable mutation"@en, "actionable mutations"@en, "actionable"@en, "matched therapy"@en, "genotype-directed"@en, "biomarker-directed"@en ;
  schema:description "Drugs designed to hit a specific molecule the cancer depends on, usually a protein made by a mutated or amplified gene, while leaving normal cells relatively alone. The tumour is tested first to see whether it carries the target."@en ;
  schema:url <https://onco.cc/terms/targeted-therapy-term/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Targeted_therapy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q492646> ;
  schema:citation <https://en.wikipedia.org/wiki/Targeted_therapy> ;
  onco:related <https://onco.cc/terms/inhibitor/>, <https://onco.cc/terms/kinase/>, <https://onco.cc/terms/driver-mutation/>, <https://onco.cc/terms/oncogene-addiction/>, <https://onco.cc/terms/genomic-profiling/>, <https://onco.cc/terms/biomarker/>, <https://onco.cc/terms/resistance/>, <https://onco.cc/terms/companion-diagnostic-term/>, <https://onco.cc/terms/chemotherapy-term/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/cdk46-inhibitor/>, <https://onco.cc/technologies/kras-inhibitors/>, <https://onco.cc/technologies/cgp/> .